InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Alhydrogel® adjuvant 2% | Perspectives on immunotherapy in prostate cancer and solid tumors: where is t... | 2013 | Semin Oncol. | Snyder A. et al. | DOI: 10.1053/j.seminoncol.2013.04.009 |
ODN 2006 FITC | Bruton's tyrosine kinase mediates the synergistic signalling between TLR9 and... | 2013 | PLoS One. | Kenny EF. et al. | DOI: 10.1371/journal.pone.0074103 |
TLR4-based adjuvant - MPLA-SM VacciGrade™ | Controlled analysis of nanoparticle charge on mucosal and systemic antibody r... | 2015 | PNAS | Fromen C.A. et al. | DOI: 10.1073/pnas.1422923112 |
LPS-RS | Pathogen-mimicking vaccine delivery system designed with a bioactive polymer ... | 2017 | J Control Release. | Tummala H. et al. | DOI: 10.1016/j.jconrel.2017.06.026 |
MDP | Triggering of NOD2 Receptor Converts Inflammatory Ly6Chigh into Ly6Clow Monoc... | 2017 | Cell Rep. | Lessard A.J. et al. | DOI: 10.1016/j.celrep.2017.08.009 |
Anti-hTLR5 Detection and Neutralizing mAb | Differential Contribution of the Aryl-Hydrocarbon Receptor and Toll-Like Rece... | 2016 | Front Cell Dev Biol. | Roussel L. et al. | DOI: 10.3389/fcell.2016.00148 |
NF-κB and NLRP3 inflammasome inhibitor - BAY 11-7082 | Synergistic proinflammatory responses by IL-17A and Toll-Like Receptor 3 in h... | 2015 | PLoS One. | Mori K. et al. | DOI: 10.1371/journal.pone.0139491 |
Zeocin® | Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infect... | 2016 | Nat Commun. | Eletto D. et al. | DOI: 10.1038/ncomms13992 |
Bafilomycin A1 | HIV-1 Env and Nef cooperatively contribute to pDCs activation via CD4-depende... | 2015 | J Virol. | Reszka-Blanco N.J. et al. | DOI: 10.1128/JVI.00695-15 |
Pam3CSK4 VacciGrade™ | NLRP3 inflammasome inhibition is disrupted in a group of auto-inflammatory di... | 2016 | Nat Immunol. | Mortimer L. et al. | DOI: 10.1038/ni.3538 |
CL264 | Cutting Edge: Endogenous IFN-β Regulates Survival and Development of Transiti... | 2017 | J Immunol. | Hamilton J.A. et al. | DOI: 10.4049/jimmunol.1700888 |
Hygromycin B Gold | C7orf30 is necessary for biogenesis of the large subunit of the mitochondrial... | 2012 | Nucleic Acids Res. | Rorbach J. et al. | DOI: 10.1093/nar/gkr1282 |
TLR4 agonist preparation - MPLA-SM | Activation of RIG-I pathway during influenza vaccination enhances germinal ce... | 2014 | J Virol. | Kulkarni R.R. et al. | DOI: 10.1128/JVI.02273-14 |
ODN D-SL03 | In vitro effects of the toll-like receptor agonists monophosphoryl lipid A an... | 2017 | Vet J. | Ziegler A. et al. | DOI: 10.1016/j.tvjl.2016.11.013 |
Ramos-Blue™ Cells | Minimal sequence requirements for oligodeoxyribonucleotides activating human ... | 2015 | J Immunol. | Pohar J. et al. | DOI: 10.4049/jimmunol.1402755 |
TLR 4 - HA | Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Hete... | 2017 | J Clin Immunol. | Ohnishi H. et al. | DOI: 10.1007/s10875-017-0417-3 |
FK506 | Critical role of mammalian target of rapamycin for IL-10 dendritic cell induc... | 2017 | J Allergy Clin Immunol. | Schülke S. et al. | DOI: 10.1016/j.jaci.2017.07.002 |
LPS-EB (LPS from E. coli O111:B4) | Sustained Endocannabinoid Signaling Compromises Decidual Function and Promote... | 2016 | J Biol Chem. | Sun X. et al. | DOI: 10.1074/jbc.M115.707836 |
ODN 2006 (ODN 7909) | Iron nanomedicines induce Toll-like receptor activation, cytokine production ... | 2017 | Biomaterials. | Verhoef J.J. et al. | DOI: 10.1016/j.biomaterials.2016.11.025 |
FLA-ST (Standard or Ultrapure) | EPCR-dependent PAR2 activation by the blood coagulation initiation complex re... | 2015 | Blood. | Liang H.P. et al. | DOI: 10.1182/blood-2014-11-610717 |